A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells (Q48026733)

7 February 2018

http://europepmc.org/abstract/MED/28744948

title

A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells (English)

1 reference

7 February 2018

http://europepmc.org/abstract/MED/28744948

author

Benjamin Sharpe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Dhafer A Alghezi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Claire Cattermole

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Mark Beresford

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Rebecca Bowen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

John Mitchard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Andrew D Chalmers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

26 July 2017

1 reference

7 February 2018

http://europepmc.org/abstract/MED/28744948

published in

The Prostate

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

1312-1324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28744948%20AND%20SRC:MED&resulttype=core&format=json

Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Chemotherapy stimulates syndecan-1 shedding: a potentially negative effect of treatment that may promote tumor relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Syndecan-1 expression in locally invasive and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Altered expression patterns of syndecan-1 and -2 predict biochemical recurrence in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Identification and location on syndecan-1 core protein of the epitopes of B-B2 and B-B4 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Plasmin- and thrombin-accelerated shedding of syndecan-4 ectodomain generates cleavage sites at Lys(114)-Arg(115) and Lys(129)-Val(130) bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

CD27 is required for generation and long-term maintenance of T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Ecto-enzyme and signaling functions of lymphocyte CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391

Microarray-based understanding of normal and malignant plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23391